Fundz

Fundz Deep Dive

Everything you need to win REMEDY Skincare — in one platform.

Who to reach, what to say, and why now on REMEDY Skincare — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on REMEDY Skincare — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

REMEDY Skincare has raised $20 million in Series A funding led by L Catterton. The funds will be used for scaling operations, clinical research, and expanding the product pipeline.

PRIVATEJun 12, 2026•3 days ago

Amount Raised

$20 Million

Round Type

series a

Health CareFashionBeautyCosmetics

Investors

NorwestSonoma Brands CapitalL Catterton

Description

Dermatologist-developed skincare brand Remedy has closed a $20 million Series A funding round led by consumer-focused private equity firm L Catterton. The investment round included Sonoma Brands Capital and Norwest. The fresh capital will scale Remedy’s operations, fund clinical research, and expand its product pipeline. The brand aims to bolster its inventory to support current retail channels.

Company Information

Company

REMEDY Skincare

About

Remedy is a skincare brand developed by board-certified dermatologist Dr. Muneeb Shah, focusing on consumer education and clinical formulation. The product range addresses common dermatological issues such as dark spots, dryness, fine lines, and sensitive skin. The brand aims to scale operations and expand its product pipeline with the recent funding. Since its launch in March 2024, Remedy has grown through direct-to-consumer channels and retail partnerships.

Related People

Suggested for you
3 contacts

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

1 more contact · See plans

Predictive Intelligence
Strategic

ML-powered predictions for REMEDY Skincare's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching REMEDY Skincare? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan